Non-stimulant treatments for ADHD

European Child and Adolescent Psychiatry

Volumn 9, Issue SUPPL. 1, 2000, Pages

  Biederman, J ^a   Spencer, T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ADHD; Non stimulant treatments

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BUSPIRONE; CLONIDINE; DESIPRAMINE; DONEPEZIL; GUANFACINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PROPRANOLOL; TACRINE;

ARTICLE; ATTENTION DEFICIT DISORDER; CHOLINERGIC TRANSMISSION; CROSS REACTION; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG EFFICACY; HUMAN; NEUROTRANSMITTER RELEASE; RISK BENEFIT ANALYSIS; SELF ESTEEM;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD PSYCHIATRY; CHILD, PRESCHOOL; CLINICAL TRIALS; HUMANS;

EID: 0033666362     PISSN: 10188827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007870070019     Document Type: Article

References (118)

1. Sudden death in children treated with a tricyclic antidepressant. The medical letter on drugs and therapeutics
2. DRD4 gene and susceptibility to attention deficit hyperacitivy disorder: Differences in familial and sporadic cases
3. A review of stimulant drug research with hyperactive children
4. Treatment of ADHD with fluoxetine: A preliminary trial
5. Bupripion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder
6. Family-environmental risk factors for attention deficit hyperactivity disorder: A test of Rutter's indicators of adversity
7. A naturalistic study of 24-hour electrocardiographic recordings and echocardigraphic findings in children and adolescents treated with desipramine
8. A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: III. Lack of impact of comorbidity and family history factors on clinical response
9. A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: I. Efficacy
10. Further evidence for family-genetic risk factors in attention deficit hperactivity disorder. Comborbidity in probands and relatives in psychiatrically and pediatrically referred samples
11. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder
12. Desipramine in the treatment of children with attention deficit disorder
13. Systematic chart review of the pharmacologic treatment of comorbid ADHD in youth with bipolar disorder
14. Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children
15. Pindolol and methylphenidate in children with attention deficit hyperactivity disorder
16. Bupropion in children with attention deficit disorder
17. A double-blind trial of bupropion in children with attention deficit disorder
18. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose
19. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome
20. A pilot study of nadolol for overt aggression in developmentally delayed individuals
21. Bupropion hydrochloride in attention deficit disorder with hyperactivity
22. An indication for the use of imipramine in attention deficit disorder
23. Genetic latent structure analysis of dysmorphology in attention deficit hyperacitivy disorder
24. The use of imipramine in Tourette's syndrome and attention deficit disorder: Case report
25. Response of children with ADHD to methylphenidate: Interaction with internalizing symptoms
26. Is attention deficit hyperactivity disorder familial?
27. Segregation analysis of attention deficit hyperactivity disorder: Evidence for single gene transmission
28. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder
29. Venlafaxine in adults with ADHD: An open trial
30. Risperidoen treatment for juvenile bipolar disorder
31. Postnatal behavioural effects of maternal nicotine exposure in rats
32. Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems
33. Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings
34. Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder (published erratum appears in Arch Gen Psychiatry 1995 10: 836)
35. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder
36. Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children
37. Desipramine in the treatment of attention deficit disorder in adolescents
38. Childhood disorders
39. Hyperactive boys almost grown up: I. Psychiatric status
40. Pilot clinical trial of imipramine in hyperkinetic children
41. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents
42. Genetic factors in hyperactivity: Account for about half of the explainable variance
43. A twin study of hyperactivity: I. An examination of hyperactivity scores and categories derived from Rutter teacher and parent questionnaires
44. A twin study of hyperacitivity: II. The aetiological role of genes, family relationships and perinatal adversity
45. Clinical effects of imipramine and methylphenidate in hyperactive children
46. Imipramine in the treatment of minimal brain dysfunction in children
47. Motor performance in hyperactive children treated with imipramine
48. Long-term outcome in attention-deficit hyperactivity disorder
49. A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine
50. Guanfacine for the treatment of attention-deficit hyperactivity disorder in boys
51. The use if imipramine in children's behavior disorders
52. Treatment effects of oral and transdermal clonidine in relation to methylphenidate: An open pilot study
53. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder
54. Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial
55. Behavioral effects of prenatal exposure to nicotine in guinea pigs
56. Effects of acute subcutaneous nicotine on attention, information and short-memory in Alzheimer's disease
57. Double-blind, placebo-controlled stimulant trial in children with Tourette's syndrome and ADHD: Abstract
58. Alterations in the vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy
59. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder
60. Epinephreine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor
61. Do typical clinical doses of methylphenidate cause tics in children treated for ADHD?
62. Nicotine effects on adults with attention-deficit/hyperactivity disorder
63. A open clinical trial of buspirone in children with attention deficit/hyperactivlty disorder
64. Hyperactive boys almost grown up: V. Replication of psychiatric status
65. Adult outcome of hyperactive boys: Educational achievement, occupational rank and psychiatric status
66. Alcohol abuse and attention deficit disorder
67. Propranolol for adults with temper outbursts and residual attention deficit disorder
68. Cholinergic modulation of the content of temporal memory
69. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine
70. Pregnancy delivery and infancy complications and ADHD: Issues of gene-environment interactions
71. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children?
72. ADHD is associated with early initiation of cigarette smoking in children and adolescents
73. Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: Comparative effects upon vigilance and heart rate
74. Attention, memory and cigarette smoking
75. Effect of anxiety on cognition, behavior, and stimulant response in ADHD
76. Cigarette smoking in adult patients diagnosed with ADHD
77. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder
78. One-year follow-up of hyperactive boys treated with imipramine or methylphenidate
79. Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function
80. Imipramine and methylphenidate treatment of hyperactive boys: A double-blind comparison
81. Combination of treatments for attention deficit disorder in adults
82. Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: Preliminary clinical experience
83. Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder. A meta-analysis
84. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: A double-blind placebo-controlled study with clonidine and desipramine
85. A double-blind, controlled study of desipramine and children with ADHD and tic disorders
86. Desipramine in the treatment of children with tic disorder or Tourette's syndrome and attention deficit hyperactivity disorder
87. Pharmacotherapy of ADHD across the lifecycle: A literature review
88. A open, dose ranging study of tomoxetine in children with ADHD
89. Nortriptyline in the treatment of children with attention deficit hyperactivity disorder and tic disorder or Tourette's syndrome
90. A double-blind crossover comparison of tomoxetine and placebo in adults with ADHD
91. Comparison of clonidine response in the treatment of attention deficit hyperactivity disorder with and without comorbid tic disorder
92. Association of the D4 receptor gene in individuals with ADHD
93. Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity
94. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety
95. Wich boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour
96. Wirksamkeit und vertraglichtkeit des selektiven MAO-A-Inhibitors moclobemid bei kindern mit hyperkinetischem syndrom
97. The personality inventory for children and response to methylphenidate: Preliminary evidence for predictive validity
98. Modifications of hyperkinetic behavior by nortriptyline
99. Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children
100. Buproprion treatment of attention-deficit hyperactivity disorder in adults
101. Imipramine and methylphenidate in hyperactive children
102. The effects of cigarettes of varying yield on rapid information precessing performance
103. Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors
104. A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder
105. Nortriptyline in the treatment of attention deficit hyperactivity disorder: A chart review of 58 cases
106. A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder
107. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder
108. A pilot clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder
109. Combining methylphenidate and clonidine: A clinically sound medication option
110. Effects of imipramine and dextroamphetamine on behavior of neuropsychiatrically impaired children
111. Amitriptyline and methylphenidate treatment of behaviourally disordered children